TB-500
Symbol Tb · MW 889 Da
Synthetic fraction of Thymosin Beta-4 promoting cell migration and angiogenesis.
- Discovered
- 2012
- Half-life
- 2 hours
- Approval
- Not FDA-approved
Quick facts
- Category
- Recovery
- Route
- Injectable
- Molecular weight
- 889 Da
- Half-life
- 2 hours
- Discovered
- 2012
- Approval status
- Not FDA-approved
Reported effects
- Wound healing
- Reduced inflammation
- Improved flexibility
Overview
TB-500 is a synthetic peptide commonly associated with soft-tissue recovery, muscle repair, tendon support, ligament healing, and mobility improvement. It is related to thymosin beta-4 activity, which plays a role in cell migration, inflammation control, and tissue remodeling. TB-500 is often discussed as a recovery peptide for athletes, active individuals, and people researching injury repair. Its purpose is to support the body's natural healing processes, especially in connective tissue and muscle-related recovery. While it is widely marketed in the peptide community, human clinical evidence is still limited, so it should be presented as a research peptide rather than a guaranteed injury treatment.
Evidence context
TB-500 evidence summary
Human clinical evidence
TB-500 has an approval context listed in the Peptidic database. Approved use still depends on the specific indication, formulation, labeling, and clinician guidance.
Animal, preclinical, or formulation evidence
TB-500 may be discussed in animal, preclinical, in vitro, or early-stage research contexts. Those evidence types are useful for orientation but should not be treated as equivalent to approved human indications.
Status and evidence strength
Peptidic lists the approval status for TB-500 as Not FDA-approved. The reported effects below are reference fields from the peptide database, not medical promises. Source links are included later on the page when available so readers can continue review from primary or reputable sources.
How it's taken
- Typical Administration
- Injectable
- Typical Dosage
- No established approved dosage; commonly referenced range is 2–7.5 mg weekly
- Typical Frequency
- 1–3 times weekly
Dosing depends on the approved indication, formulation, titration schedule, and clinician guidance. This page is educational and not a substitute for medical advice.
Research sources
Source links included from peer-reviewed literature, clinical records, and medical databases for educational research context on TB-500.
Internal links
Related peptides
Frequently asked questions
What category is TB-500 in?
TB-500 is listed in the Recovery category on Peptidic.
What route is TB-500 associated with?
TB-500 is associated with the injectable route in the Peptidic database. This is descriptive route context, not a use instruction.
Is TB-500 approved?
Peptidic lists the approval status for TB-500 as: Not FDA-approved. Approval details can vary by indication and jurisdiction.
Interested in TB-500?
Enter your email and we'll send our recommended peptide vendor for educational research reference.
Review the peptide vendor research checklistEducational reference only · No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions. Explore the full peptide database, peptide calculator, or peptide tracker.
Last reviewed for educational accuracy: 2026-06-01